www.fdanews.com/articles/177633-inova-nabs-fda-clearance
Inova Nabs FDA Clearance
July 21, 2016
Inova Diagnostics has earned FDA clearance for its QUANTA Flash dsDNA, QUANTA Flash Jo-1, and QUANTA Flash Scl-70 assays, the California-based company announced Wednesday.
The dsDNA is designed to facilitate the diagnosis of systemic lupus erythematosus, whereas Jo-1 and Scl-70 are designed to detect myositis and systemic sclerosis, respectively, the company said. — Anisa Jibrell